RecruitingNCT07230652
Safety and Tolerability of LY03020
This study is recruiting in China. It focuses on Schizophrenia.
In BeijingSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingISRCTN25163383
Study to assess the safety and PK of novel CBD soft-gel capsule
This study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 55 Years
RecruitingNCT05995782
SAD and MAD Study Safety and Tolerability of FB418
This study is recruiting in South Korea. It focuses on Schizophrenia.
In SeoulSchizophreniaDrugOver 19 Years
RecruitingNCT07115329
Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
This study is recruiting in the United States. It is testing zelquistinel or Placebo for depression.
Multiple locations, including PhoenixDepressionDrugFrom 18 Years to 64 Years
RecruitingNCT07478744
Safety study of SYT-510 in anxiety
This study is recruiting in the United Kingdom. It is testing SYT-510 for anxiety.
In LondonAnxietyDrugFrom 18 Years to 55 Years
RecruitingNCT06236880
Safety study of GM-2505 in Depression
This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.
In ManchesterDepressionDrugFrom 18 Years to 65 Years
RecruitingISRCTN33909010
Placebo- and active comparator-controlled, study to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic people with schizophrenia
This study is recruiting in the United Kingdom, in Bulgaria, in Colombia, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
RecruitingNCT07592689
Study of DT120 for Major Depressive Disorder (Ascend)
This study is recruiting in the United States. It focuses on depression.
Multiple locations, including GilbertDepressionOtherFrom 18 Years to 74 Years
RecruitingISRCTN44297014
A phase III active comparator-controlled study to study the safety and efficacy of lurasidone in subjects with schizophrenia (PEARL 3 extension study)
This study is recruiting in the United States, in Colombia, in Germany, .... It focuses on schizophrenia.
In ColombiaSchizophreniaOtherFrom 18 Years to 75 Years
RecruitingISRCTN16838597
A phase three study to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic people with schizophrenia
This study is recruiting in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
RecruitingNCT06349915
A Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents
This summary needs review. Please check the official study record and contact the research team for details.
In The BronxSuicidalityBehavioralFrom 14 Years to 18 Years
RecruitingISRCTN95300084
A investigation of a single session of stimulation of the left frontal brain area applying a technique that delivers localised magnetic waves through the skull (repetitive transcranial magnetic stimulation [rTMS]) in people with a bulimic Eating disorders (e.g. Eating disorders and binge-Eating disorders) who engage in binge-eating behaviour and its effect on craving, bingeing behaviour and mood and stress
This study is recruiting in the United Kingdom. It focuses on Eating disorders.
In United KingdomEating disordersOtherOver 18 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.